Cite

HARVARD Citation

    Heller, S. et al. (2018). The effect of basal–bolus therapy varies with baseline 1, 5‐anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis. Diabetic medicine. 35 (9), pp. 1273-1278. [Online]. 
  
Back to record